Track The Beauty Health Company Class A Common Stock — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

The Beauty Health Company Class A Common Stock SKIN · Stock Open The Beauty Health Company Class A Common Stock in new tab

16.47 USD
EPS
-3.03
P/B
1.91
ROE
-30.13
Beta
1.06
Target Price
14.50 USD
The Beauty Health Company Class A Common Stock logo

The Beauty Health Company Class A Common Stock

🧾 Earnings Recap – Q1 2026

SkinHealth Systems’ stock plunged 26.4% following a disappointing earnings report driven primarily by a lowered full-year revenue outlook and continued softness in device placements amid challenging macro conditions and intensified competition.

  • Q1 net sales were $64.9 million, within guidance, but device placements fell short of expectations due to tighter credit markets and longer purchasing cycles.
  • The company cut full-year revenue guidance by roughly 2.5%, reflecting persistent capital equipment demand weakness and a slow payoff from commercial improvements.
  • Consumables revenue declined 6.1% year-over-year, mostly due to a distributor transition in China, with other regional timing variabilities noted.
  • Active installed base grew 4% year-over-year to 36,400 devices, while device churn improved, declining 40%, signaling better provider retention.
  • Despite top-line challenges, adjusted EBITDA rose 17% year-over-year to $8.5 million, beating guidance amid margin expansion to 72.2%, driven by operational discipline and ongoing investments.
📅
Loading chart...
Key Metrics
Earnings dateMarch 11, 2027
EPS-3.03
Book Value8.56
Price to Book1.91
Debt/Equity473.92
% Insiders12.922%
Growth
Revenue Growth-0.02%
Earnings Growth96.58%
Estimates
Forward P/E3.64
Forward EPS4.48
Target Mean Price14.50

DCF valuation

Model fair value for The Beauty Health Company Class A Common Stock (SKIN)
Result
Sign in to run the valuation for SKIN.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–
Analyst price targets
6 analysts · consensus Hold · mean target 14.50 USD (low 10.00, high 24.00) · as of 15 Nov 2026
Low 10.00
Mean 14.50
High 24.00
Price 16.47
Published broker research as supplied by our market data feed, named by firm and dated; it does not identify individual analysts. Targets carry their last refresh date; rating changes can be a few days behind.

The Beauty Health Company Class A Common Stock Logo The Beauty Health Company Class A Common Stock Analysis (SKIN)

United States Consumer Staples Official Website Stock

Is The Beauty Health Company Class A Common Stock a good investment? The Beauty Health Company Class A Common Stock (SKIN) is currently trading at 16.47 USD. Market analysts have a consensus price target of 14.50 USD. This suggests the asset is currently trading above analyst expectations.

Earnings Schedule: The Beauty Health Company Class A Common Stock is expected to release its next earnings report on March 11, 2027. The market consensus estimate for Forward EPS is 4.48.

Investor FAQ

Does The Beauty Health Company Class A Common Stock pay a dividend?

No, it does not currently pay a dividend.

What asset class is The Beauty Health Company Class A Common Stock?

The Beauty Health Company Class A Common Stock is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be March 11, 2027. The company currently has a trailing EPS of -3.03.

Company Profile

SkinHealth Systems Inc., a global medical aesthetics company delivering an integrated ecosystem of clinically proven solutions in the Americas, the Asia-Pacific, Europe, the Middle East, Africa, Canada, and Latin America. The company's flagship product is HydraFacial, which enhances the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. It also offers Syndeo devices, which are delivery systems that are designed to connect providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling and nanoneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive peptide solutions and take home sprays for treating scalp health. In addition, it operates the MyBeautyHealth mobile application for consumers to earn loyalty points and unlock savings, log skin concerns and receive personalized treatment plans, and find and connect with Hydrafacial providers, as well as offers boosters. The company was formerly known as The Beauty Health Company and changed its name to SkinHealth Systems Inc. in April 2026. The company was founded in 1997 and is headquartered in Long Beach, California.

Exchange Ticker
NMS (United States) SKIN
Trades
Dividend History paid per year (USD)
No dividend history available.
Stock Splits
Split Date Split Ratio to 1
Oct. 14, 2026 1:20
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion